Abstract
PURPOSE: Several authorities have documented a significant decrease in support for modern eye pathology/pathology research laboratories. Indeed, many laboratories have closed or suffered marked cutbacks. The purpose of this report is to ask why this is so and to seek a possible means for reversing this trend. METHODS: Observations from the senior author's experience and a case from author's facility are analyzed. RESULTS: There are several reasons for ocular pathologists' difficulties, such as financial problems, lack of vision, personality conflicts, and problems with the departmental administration. Until recently, most research and development in several subspecialty fields of ophthalmology, including biodevices research, has been done primarily by engineers and in-house workers in industry. This precludes proper independent, nonbiased control and guidance from academia. Most ocular pathologists have not participated in this relatively new and wide-open field. CONCLUSIONS: We suggest a new realm of activity for today's newly trained ocular pathologists. Based on personal experience of two decades of fruitful collaboration with industry, we believe that ocular pathologists are uniquely trained to apply their expertise to various new fields of research that most pathologists today have not utilized. An important example is research on clinicopathological aspects of implantable biodevices. In addition, support and oversight should be provided by the major ophthalmic societies, such as the American Academy of Ophthalmology, in order to retain (even regain) control over this field. This is mandatory in order to control the safety and efficacy of new drugs and devices being introduced almost daily. Only then can clear differentiation between profit and patient welfare be achieved as potentially dangerous devices and techniques are let loose on the market. The field of "routine, descriptive" eye pathology is severely wounded and will return only in an attenuated fashion. In general, full-time support for ocular pathologists will not be possible unless they seek extra support from the private sector, engage in a concurrent clinical practice, or are supported by an endowed chair (a wonderful alternative).
Full Text
The Full Text of this article is available as a PDF (392.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Apple D. J., Lim E. S., Morgan R. C., Tsai J. C., Gwin T. D., Brown S. J., Carlson A. N. Preparation and study of human eyes obtained postmortem with the Miyake posterior photographic technique. Ophthalmology. 1990 Jun;97(6):810–816. doi: 10.1016/s0161-6420(90)32507-1. [DOI] [PubMed] [Google Scholar]
- Apple D. J., Peng Q., Visessook N., Werner L., Pandey S. K., Escobar-Gomez M., Ram J., Whiteside S. B., Schoderbeck R., Ready E. L. Surgical prevention of posterior capsule opacification. Part 1: Progress in eliminating this complication of cataract surgery. J Cataract Refract Surg. 2000 Feb;26(2):180–187. doi: 10.1016/s0886-3350(99)00353-3. [DOI] [PubMed] [Google Scholar]
- Klintworth G. K. Ashton lecture. Ophthalmic pathology from its beginning to the high technology of this millennium. Eye (Lond) 2001 Oct;15(Pt 5):569–577. doi: 10.1038/eye.2001.187. [DOI] [PubMed] [Google Scholar]
- Koch Douglas D. Industry support for physician education. J Cataract Refract Surg. 2003 Mar;29(3):419–419. doi: 10.1016/s0886-3350(03)00105-6. [DOI] [PubMed] [Google Scholar]
- Miyake K., Miyake C. Intraoperative posterior chamber lens haptic fixation in the human cadaver eye. Ophthalmic Surg. 1985 Apr;16(4):230–236. [PubMed] [Google Scholar]
- Parsons M. A. Whither ophthalmic pathology in the UK: why not wither and whemmie? Eye (Lond) 2001 Oct;15(Pt 5):565–567. doi: 10.1038/eye.2001.186. [DOI] [PubMed] [Google Scholar]
- Peng Q., Apple D. J., Visessook N., Werner L., Pandey S. K., Escobar-Gomez M., Schoderbek R., Guindi A. Surgical prevention of posterior capsule opacification. Part 2: Enhancement of cortical cleanup by focusing on hydrodissection. J Cataract Refract Surg. 2000 Feb;26(2):188–197. doi: 10.1016/s0886-3350(99)00354-5. [DOI] [PubMed] [Google Scholar]
- Peng Q., Visessook N., Apple D. J., Pandey S. K., Werner L., Escobar-Gomez M., Schoderbek R., Solomon K. D., Guindi A. Surgical prevention of posterior capsule opacification. Part 3: Intraocular lens optic barrier effect as a second line of defense. J Cataract Refract Surg. 2000 Feb;26(2):198–213. doi: 10.1016/s0886-3350(99)00352-1. [DOI] [PubMed] [Google Scholar]
- Sillito A, Luthert P. Norman henry ashton CBE, DSC (LOND), FRCP, FRCS, FRCPATH, FRCOPHTH, FRS, KSTJ, b 11 september 1913, d 4 january 2000. Br J Ophthalmol. 2000 Apr;84(4):443–443. doi: 10.1136/bjo.84.4.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spencer W. H. Ophthalmic pathology at the crossroads. Arch Ophthalmol. 2001 Aug;119(8):1204–1205. doi: 10.1001/archopht.119.8.1204. [DOI] [PubMed] [Google Scholar]
- Werner L., Apple D. J., Escobar-Gomez M., Ohrström A., Crayford B. B., Bianchi R., Pandey S. K. Postoperative deposition of calcium on the surfaces of a hydrogel intraocular lens. Ophthalmology. 2000 Dec;107(12):2179–2185. doi: 10.1016/s0161-6420(00)00416-4. [DOI] [PubMed] [Google Scholar]
- Werner L., Apple D. J., Kaskaloglu M., Pandey S. K. Dense opacification of the optical component of a hydrophilic acrylic intraocular lens: a clinicopathological analysis of 9 explanted lenses. J Cataract Refract Surg. 2001 Sep;27(9):1485–1492. doi: 10.1016/s0886-3350(01)00841-0. [DOI] [PubMed] [Google Scholar]
- Werner L., Pandey S. K., Apple D. J., Escobar-Gomez M., McLendon L., Macky T. A. Anterior capsule opacification: correlation of pathologic findings with clinical sequelae. Ophthalmology. 2001 Sep;108(9):1675–1681. doi: 10.1016/s0161-6420(01)00674-1. [DOI] [PubMed] [Google Scholar]
- Werner L., Pandey S. K., Escobar-Gomez M., Visessook N., Peng Q., Apple D. J. Anterior capsule opacification: a histopathological study comparing different IOL styles. Ophthalmology. 2000 Mar;107(3):463–471. doi: 10.1016/s0161-6420(99)00088-3. [DOI] [PubMed] [Google Scholar]
